Overview

Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare pharmacogenetics plus drug combination (Schisandra sphenanthera extract,SchE)guided and standard initial tacrolimus dosage.

Phase:

N/A

Details

Lead Sponsor:

Sun Yat-sen University

Collaborator:

First Affiliated Hospital, Sun Yat-Sen University

Treatments:

Tacrolimus